Clinical Trial

Bioequivalence Study of WP205 in Healthy Subjects

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a single-center, randomized, open-label, two-period, two-sequence, single-dose, crossover bioequivalence trial conducted under fasting conditions in healthy adult volunteers. Participants will be randomized into two sequences (A and B). Each participant will receive a single intramuscular dose of the test or reference formulation according to the assigned sequence, with an adequate washout period between dosing. The primary objective of the study is to evaluate the bioequivalence of the two formulations.
Trial Details
NCT Number NCT07158099
Lead Sponsor Wanbangde Pharmaceutical Group Co., LTD
Conditions Therapeutic Equivalency, Healthy
Enrollment 14 participants
Start Date 2025-09-15
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-05